Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07700303
What this trial is testing

Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)

Who this might be right for
Pulmonary Arterial Hypertension
University of Alberta 78
Post-approval studies (Phase 4)Study completedNCT00323297
What this trial is testing

Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 105
Not applicableUnknownNCT02198456
What this trial is testing

Imaging Control Study, 3D Echo, MR and RHC.

Who this might be right for
Pulmonary Arterial Hypertension WHO Group I
Regina Steringer-Mascherbauer 12
Post-approval studies (Phase 4)Study completedNCT02191137
What this trial is testing

Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)

Who this might be right for
Hypertension, Pulmonary
Bayer 75
Large-scale testing (Phase 3)WithdrawnNCT00780728
What this trial is testing

Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
University Health Network, Toronto
Early research (Phase 1)Study completedNCT04994860
What this trial is testing

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 20
Post-approval studies (Phase 4)Study completedNCT00082186
What this trial is testing

The Effect of Tracleer® on Male Fertility

Who this might be right for
Hypertension, Pulmonary
Actelion 22
Not applicableUnknownNCT03049995
What this trial is testing

Stress Echo 2020 - The International Stress Echo Study

Who this might be right for
Coronary Artery DiseaseHeart FailureHypertrophic Cardiomyopathy+4 more
Fatebenefratelli Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT05975905
What this trial is testing

Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Who this might be right for
Pulmonary Arterial Hypertension
Keros Therapeutics, Inc. 113
Large-scale testing (Phase 3)Ended earlyNCT03068130
What this trial is testing

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER

Who this might be right for
Pulmonary Hypertension
Biogen 261
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Large-scale testing (Phase 3)Study completedNCT00549302
What this trial is testing

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Who this might be right for
Hypertension, Pulmonary
Eli Lilly and Company 357
Not applicableUnknownNCT03954405
What this trial is testing

Multi-marker Approach for Risk Assessment in PAH

Who this might be right for
Pulmonary Arterial Hypertension
Wuhan Asia Heart Hospital 500
Large-scale testing (Phase 3)Ended earlyNCT02657356
What this trial is testing

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Who this might be right for
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Biogen 202
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Early research (Phase 1)Ended earlyNCT01795950
What this trial is testing

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 6
Not applicableActive Not RecruitingNCT06587074
What this trial is testing

Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Russian Cardiology Research and Production Center 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06925750
What this trial is testing

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 130
Testing effectiveness (Phase 2)Looking for participantsNCT07318597
What this trial is testing

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Regeneron Pharmaceuticals 99
Large-scale testing (Phase 3)Study completedNCT00159874
What this trial is testing

A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 234
Next Page